Open access · CC-BY
via OpenAlex
Melatonin Ameliorates Age‐Related Sarcopenia via the Gut–Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites
Lingshan Zhou, Yuan Yang, Li Mou, Xin Xia, Min Liu, Lingjie Xu, Rong Liu, Junping Liu, Haiyan Zhang, Xiao‐Jun Ao, Chang‐Jiang Liu, Qian Xiao, Shi‐Xiong Liu
Journal of Cachexia Sarcopenia and Muscle · 2025 · ▲ 18 citations
Abstract
BACKGROUND: Sarcopenia affects the quality of life and increases adverse outcomes in the elderly. However, as a potential safe and effective remedy to many age-related disorders, little is known about the protective effect of melatonin against sarcopenia, especially the underlying mechanisms of pathophysiology related to the gut-muscle axis. METHODS: The young (4 months) and old-aged (24 months) wild-type C57BL/6J male mice were included in this study, of which the old-aged mice in the experimental group were treated with 10 mg/kg/day of melatonin for 16 weeks. After that, muscle strength, muscle mass and the cross-sectional area (CSA) of the gastrocnemius muscle fibres were measured. Then, the putative pathways, based on the data obtained from 16S rDNA sequencing of the gut microbiota, RNA sequencing of gastrocnemius muscle and serum untargeted metabolomics, were screened out by the integrated multiomics analysis and validated using immunohistochemistry, ELISA and TUNEL staining. C2C12 myoblasts were treated with LPS. Flow cytometric analysis and western blotting were applied to detect cell apoptosis and protein expressions of Tnfrsf12a and caspase8, respectively. In addition, the mediation analysis was carried out to infer the causal role of the microbiome in contributing to the skeletal muscle through metabolites. RESULTS: Melatonin treatment ameliorated age-related declines in muscle strength (p < 0.05), muscle mass (p < 0.01) and CSA of the gastrocnemius muscle fibres (p < 0.01), as well as changed the gut microbial composition (beta-diversity analysis; R = 0.513, p = 0.005). The integrated multiomics analysis implied two main mechanisms about the impact of melatonin-related modifications in the gut microbiota on sarcopenia. First, a lower serum lipopolysaccharide (LPS) level associated with the altered gut microbiota was observed in melatonin-treated mice (p < 0.001) and was most relevant to the transcription level of Tnfrsf12a in skeletal muscle (R = 0.926, p < 0.001). Further bioinformatics analyses and in vitro experiments showed that LPS could contribute to skeletal muscle apoptosis by regulating the Tnfrsf12a/caspase-8 signalling pathway. Second, melatonin significantly altered serum metabolites (variable importance on projection (VIP) > 1.5, p < 0.05). Mediation models showed that changes in the gut microbiome also influenced skeletal muscle through these metabolites (27 linkages; BH-adjusted p < 0.05). CONCLUSIONS: Our study revealed functional insights and a putative causality for the role of the gut-muscle axis in the mechanism of melatonin ameliorating age-related sarcopenia, namely, inhibition of the LPS-induced Tnfrsf12a/caspase-8 signalling pathway or serum metabolites as intermediates in the gut-muscle axis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/jcsm.13722
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Zhou, L., Yang, Y., Mou, L., Xia, X., Liu, M., Xu, L., Liu, R., Liu, J., Zhang, H., Ao, X., Liu, C., Xiao, Q., & Liu, S. (2025). Melatonin Ameliorates Age‐Related Sarcopenia via the Gut–Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites. <em>Journal of Cachexia Sarcopenia and Muscle</em>. https://doi.org/10.1002/jcsm.13722
Vancouver
Zhou L, Yang Y, Mou L, Xia X, Liu M, Xu L, et al. Melatonin Ameliorates Age‐Related Sarcopenia via the Gut–Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites. Journal of Cachexia Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13722.
BibTeX
@article{lingshan2025Melato,
title = {Melatonin Ameliorates Age‐Related Sarcopenia via the Gut–Muscle Axis Mediated by Serum Lipopolysaccharide and Metabolites},
author = {Lingshan Zhou and Yuan Yang and Li Mou and Xin Xia and Min Liu and Lingjie Xu and Rong Liu and Junping Liu and Haiyan Zhang and Xiao‐Jun Ao and Chang‐Jiang Liu and Qian Xiao and Shi‐Xiong Liu},
journal = {Journal of Cachexia Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.13722},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cachexia Sarcopenia and Muscle 2021
Open access · CC-BY
Understanding the gut microbiota and sarcopenia: a systematic review
International Journal of Molecular Sciences 2021
Open access · CC-BY
Lactobacillus plantarum HY7715 Ameliorates Sarcopenia by Improving Skeletal Muscle Mass and Function in Aged Balb/c Mice
Frontiers in Microbiology 2025
Open access · CC-BY
Gut-muscle axis crosstalk in age-related sarcopenia: mechanisms and therapeutic targets
Nutrients 2018
Open access · CC-BY
Dietary Protein and Muscle in Aging People: The Potential Role of the Gut Microbiome
Frontiers in aging neuroscience 2026
Citation only
Gut microbial characteristics and kynurenine-related metabolism across sarcopenia groups: associations with neuromuscular and physical function.
Frontiers in Cellular and Infection Microbiology 2019
Open access · CC-BY